KK
NAMS icon

KLP Kapitalforvaltning’s NewAmsterdam Pharma NAMS Stock Holding History

KLP Kapitalforvaltning’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$464K Buy
13,700
+3,800
+38% +$125K ﹤0.01% 1536
2026
Q1 		$317K Buy
9,900
+800
+9% +$26.1K ﹤0.01% 1635
2025
Q4 		$319K Hold
9,100
– – ﹤0.01% 1637
2025
Q3 		$259K Hold
9,100
– – ﹤0.01% 1708
2025
Q2 		$165K Buy
9,100
+3,100
+52% +$56.5K ﹤0.01% 1859
2025
Q1 		$123K Hold
6,000
– – ﹤0.01% 1947
2024
Q4 		$154K Buy
+6,000
New +$127K ﹤0.01% 1928

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

KLP Kapitalforvaltning's NAMS Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its NewAmsterdam Pharma (NAMS) stake by 38% in Q2 2026, buying an estimated $125K and bringing the position to 13,700 shares worth $464K. The position accounts for ﹤0.01% of the portfolio, ranked #1536.

KLP Kapitalforvaltning first reported a position in NAMS in Q4 2024 and has held it in 7 quarters since. 194 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • KLP Kapitalforvaltning held 13,700 shares of NewAmsterdam Pharma worth $464K as of Q2 2026.
  • KLP Kapitalforvaltning bought 3,800 NewAmsterdam Pharma shares in Q2 2026, an estimated $125K.
  • NewAmsterdam Pharma made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1536 holding.
  • KLP Kapitalforvaltning first reported a position in NewAmsterdam Pharma in Q4 2024 and has held it in 7 quarters since.
  • 194 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.